Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.70 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.44 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.42 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.41 |
| ▸ | KDM4A | O75164 | 1/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.40 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.40 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.40 |
| ▸ | NAMPT | P43490 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15981282 | 1.00 | KDM4E (0.70) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL21227771 | 1.00 | KDM4E (0.70) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL20859598 | 1.00 | KDM4E (0.70) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL4762422 | 0.98 | KDM4E (0.65) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL4762361 | 0.91 | KDM4E (0.61) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL21106551 | 0.88 | KDM4E (0.53) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL21106927 | 0.87 | KDM4E (0.52) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL15238241 | 0.84 | EPHX1 (0.60) | KDM4EMAPK1HIF1AEPHX1KDM4C | |
| SCHEMBL14739904 | 0.83 | KDM4E (1.00) | KDM4EMAPK1HIF1APAOXADRA1A | |
| SCHEMBL1900654 | 0.83 | KDM4E (1.00) | KDM4EMAPK1HIF1APAOXADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-7179339-A | — | — | None | — | — | JP | disclosed |
| JP-6092844-A | — | — | None | — | — | JP | disclosed |
| US-20250387442-A1 | BACTERIA-TARGETING CAPSID PARTICLE, TREATMENT COMPOSITION, DISINFECTANT, FOOD, BACTERIA ELIMINATION METHOD, BACTERICIDAL METHOD, CORROSION PREVENTION METHOD, ANIMAL TREATMENT METHOD, GENE INTRODUCTION METHOD, BACTERIA FUNCTION ADDITION METHOD, METHOD FOR PRODUCING BACTERIA-TARGETING CAPSID PARTICLE, AND METHOD FOR PRODUCING NUCLEIC ACID FOR BACTERIA-TARGETING CAPSID PARTICLE | JICHI MEDICAL UNIVERSITY (JP) | 2025-12-25 | — | — | US | disclosed |
| US-20250295713-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES | DERMBIONT, INC. | 2025-09-25 | — | — | US | disclosed |
| EP-4549558-A1 | BACTERIA-TARGETING CAPSID PARTICLE, TREATMENT COMPOSITION, DISINFECTANT, FOOD, METHOD FOR ELIMINATING BACTERIA, STERILIZATION METHOD, METHOD FOR PREVENTING DECAY, METHOD FOR TREATING ANIMAL, METHOD FOR INTRODUCING GENE, METHOD FOR ADDING BACTERIA FUNCTION, METHOD FOR PRODUCING BACTERIA-TARGETING CAPSID PARTICLE, AND METHOD FOR PRODUCING NUCLEIC ACID FOR BACTERIA-TARGETING CAPSID PARTICLE | Jichi Medical University (JP) | 2025-05-07 | — | — | EP | disclosed |
| US-12064459-B2 | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes | DERMBIONT, INC. (US) | 2024-08-20 | — | — | US | disclosed |
| WO-2024004923-A1 | BACTERIA-TARGETING CAPSID PARTICLE, TREATMENT COMPOSITION, DISINFECTANT, FOOD, METHOD FOR ELIMINATING BACTERIA, STERILIZATION METHOD, METHOD FOR PREVENTING DECAY, METHOD FOR TREATING ANIMAL, METHOD FOR INTRODUCING GENE, METHOD FOR ADDING BACTERIA FUNCTION, METHOD FOR PRODUCING BACTERIA-TARGETING CAPSID PARTICLE, AND METHOD FOR PRODUCING NUCLEIC ACID FOR BACTERIA-TARGETING CAPSID PARTICLE | 学校法人自治医科大学 | 2024-01-04 | — | — | WO | disclosed |
| US-20220160617-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES | DERMBIONT, INC. | 2022-05-26 | — | — | US | disclosed |
| CN-114302953-A | Bacillus strain and method for promoting plant growth | 奥本大学 | 2022-04-08 | — | — | CN | disclosed |
| JP-2001226328-A | INTERMEDIATE OF CAPSIAMIDE AND IMPROVED METHOD FOR PRODUCING CAPSIAMIDE | GRELAN PHARMACEUT CO LTD | 2001-08-21 | — | — | JP | disclosed |
| JP-H07179339-A | ANTI-INFLAMMATORY ANALGESIC AGENT | OSAWA KEISUKE | 1995-07-18 | — | — | JP | disclosed |
| JP-H0692844-A | ANALGESIC AGENT | OSAWA KEISUKE | 1994-04-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250387442-A1 | BACTERIA-TARGETING CAPSID PARTICLE, TREATMENT COMPOSITION, DISINFECTANT, FOOD, BACTERIA ELIMINATION METHOD, BACTERICIDAL METHOD, CORROSION PREVENTION METHOD, ANIMAL TREATMENT METHOD, GENE INTRODUCTION METHOD, BACTERIA FUNCTION ADDITION METHOD, METHOD FOR PRODUCING BACTERIA-TARGETING CAPSID PARTICLE, AND METHOD FOR PRODUCING NUCLEIC ACID FOR BACTERIA-TARGETING CAPSID PARTICLE | CLPP, CAPG, RNGTT | KDM4E 4082/4885MAPK1 3137/4885HIF1A 1775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.